NCT07526493 2026-04-13Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.Tongji HospitalPhase 1 Recruiting6 enrolled